EXL

Elixinol Wellness Limited

AU Healthcare Drug Manufacturers - Specialty & Generic

52-week price-52.9%

Latest week: 4 Sep 2026
Weekly close: 0.008 AUD
Fair value: 0.0289 AUD
Next-week expectancy: Negative 28.24%

Seven-day news and sentiment · 30 August–5 September 2026

Recent company news leans constructive

Positive company coverage has outnumbered negative coverage across the last seven days.

Open news and sentiment summary →

Headlines · 7 days5

Publishers3

Headline balance3+ · 0−2 neutral

30-day weighted score55/100Neutral · Held steady

31 Aug, 09:05
Kalkine · Main companyElixinol Wellness (ASX:EXL) H1 FY2026 Results: EBITDA Loss Shrinks to $0.1 Million as Margins Expand
31 Aug, 08:20
marketscreener.com · Main companyElixinol Wellness Limited Reports Earnings Results for the Half Year Ended June 30, 2026
31 Aug, 07:32
TipRanks · Main companyElixinol Wellness Narrows Loss and Reshapes Portfolio With US Exit

Completed daily analysis

Preparing this listing’s daily history

The live session price remains available above. Completed OHLCV history is fetched on demand for listings that are opened, so the rest of the market does not need a daily collection pass.

Daily history update queued A background task is preparing missing or newer completed sessions. Refresh this page shortly.

Other market evidence

What else has changed

Latest stored top-level readings; badges identify evidence updated since the weekly anchor.

Factors

Mixed factor ranking

Overall factor rank 39/100 in Australia - AUD.Open factors →

EXL

Delayed price and five-minute path